|
US3634584A
(en)
*
|
1969-02-13 |
1972-01-11 |
American Home Prod |
Sustained action dosage form
|
|
GB1468172A
(en)
*
|
1973-03-28 |
1977-03-23 |
Benzon As Alfred |
Oral drug preparations
|
|
US3954959A
(en)
*
|
1973-03-28 |
1976-05-04 |
A/S Alfred Benzon |
Oral drug preparations
|
|
DE2336218C3
(de)
*
|
1973-07-17 |
1985-11-14 |
Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz |
Orale Arzneiform
|
|
DD146547A5
(de)
*
|
1978-07-15 |
1981-02-18 |
Boehringer Sohn Ingelheim |
Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
|
|
CH647676A5
(fr)
*
|
1978-12-22 |
1985-02-15 |
Donald E Panoz |
Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
|
|
DE3000979A1
(de)
*
|
1980-01-12 |
1981-07-23 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
|
|
DE3124090A1
(de)
*
|
1981-06-19 |
1983-01-05 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue orale dipyridamolformen
|
|
DE3126703A1
(de)
*
|
1981-07-07 |
1983-01-27 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Bromhexin-retardform und verfahren zu ihrer herstellung
|
|
DE3237575A1
(de)
*
|
1982-10-09 |
1984-04-12 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue orale mopidamolformen
|
|
IE55745B1
(en)
*
|
1983-04-06 |
1991-01-02 |
Elan Corp Plc |
Sustained absorption pharmaceutical composition
|
|
IE56459B1
(en)
*
|
1983-12-21 |
1991-08-14 |
Elan Corp Ltd |
Controlled absorption pharmaceutical formulation
|
|
IE56999B1
(en)
*
|
1983-12-22 |
1992-03-11 |
Elan Corp Plc |
Pharmaceutical formulation
|
|
US4894240A
(en)
*
|
1983-12-22 |
1990-01-16 |
Elan Corporation Plc |
Controlled absorption diltiazem formulation for once-daily administration
|
|
EP0225085A1
(en)
*
|
1985-11-13 |
1987-06-10 |
ELAN CORPORATION, Plc |
Controlled absorption pharmaceutical formulation
|
|
GB2189698A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
|
IE58401B1
(en)
*
|
1986-06-20 |
1993-09-08 |
Elan Corp Plc |
Controlled absorption pharmaceutical composition
|
|
DE3627423A1
(de)
*
|
1986-08-13 |
1988-02-18 |
Thomae Gmbh Dr K |
Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
|
|
AU2016992A
(en)
*
|
1991-05-20 |
1992-12-30 |
Marion Laboratories, Inc. |
Multi-layered controlled release formulation
|
|
US5464632C1
(en)
*
|
1991-07-22 |
2001-02-20 |
Prographarm Lab |
Rapidly disintegratable multiparticular tablet
|
|
US5837284A
(en)
*
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5705190A
(en)
*
|
1995-12-19 |
1998-01-06 |
Abbott Laboratories |
Controlled release formulation for poorly soluble basic drugs
|
|
US5840329A
(en)
*
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
|
DE69901938T3
(de)
*
|
1998-03-06 |
2012-08-02 |
Aptalis Pharma S.R.L. |
Schnell zerfallende tablette
|
|
US6602521B1
(en)
*
|
1998-09-29 |
2003-08-05 |
Impax Pharmaceuticals, Inc. |
Multiplex drug delivery system suitable for oral administration
|
|
HU230454B1
(hu)
*
|
1998-11-02 |
2016-07-28 |
Alkermes Pharma Ireland Limited |
Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
|
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6936275B2
(en)
*
|
1999-12-20 |
2005-08-30 |
Scolr, Inc. |
Amino acid modulated extended release dosage form
|
|
JP2004508278A
(ja)
*
|
2000-01-20 |
2004-03-18 |
デルシス ファーマシューティカル コーポレイション |
多段薬物投与形態
|
|
US6627223B2
(en)
*
|
2000-02-11 |
2003-09-30 |
Eurand Pharmaceuticals Ltd. |
Timed pulsatile drug delivery systems
|
|
US6500457B1
(en)
*
|
2000-08-14 |
2002-12-31 |
Peirce Management, Llc |
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
|
|
WO2003000169A1
(fr)
*
|
2001-06-20 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
Procede de fabrication de comprimes
|
|
DE10149674A1
(de)
*
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
US20040019096A1
(en)
*
|
2001-10-23 |
2004-01-29 |
Vlassios Andronis |
Novel formulations of carvedilol
|
|
US6663888B2
(en)
*
|
2001-12-14 |
2003-12-16 |
Eurand Pharmaceuticals Ltd. |
Pulsatile release histamine H2 antagonist dosage form
|
|
MY143789A
(en)
*
|
2003-02-18 |
2011-07-15 |
Helsinn Healthcare Sa |
Use of palonosetron treating post- operative nausea and vomiting
|
|
US20040265375A1
(en)
*
|
2003-04-16 |
2004-12-30 |
Platteeuw Johannes J. |
Orally disintegrating tablets
|
|
US8545881B2
(en)
*
|
2004-04-19 |
2013-10-01 |
Eurand Pharmaceuticals, Ltd. |
Orally disintegrating tablets and methods of manufacture
|
|
US9050249B2
(en)
*
|
2004-04-30 |
2015-06-09 |
Astellas Pharma Inc. |
Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition
|
|
US20060280795A1
(en)
*
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
CA2635313C
(en)
*
|
2005-12-29 |
2013-12-31 |
Osmotica Corp. |
Triple combination release multi-layered tablet
|
|
KR20140088230A
(ko)
*
|
2006-01-27 |
2014-07-09 |
앱탈리스 파마테크, 인코포레이티드 |
약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
|
|
AU2007211091B8
(en)
*
|
2006-01-27 |
2013-08-29 |
Adare Pharmaceuticals, Inc. |
Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids
|
|
NZ576237A
(en)
*
|
2006-10-24 |
2011-12-22 |
Helsinn Healthcare Sa |
Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
|
|
US8133506B2
(en)
*
|
2008-03-12 |
2012-03-13 |
Aptalis Pharmatech, Inc. |
Drug delivery systems comprising weakly basic drugs and organic acids
|